Asansol, India

Ananya Saha

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ananya Saha: Innovator in Pharmaceutical Formulations

Introduction

Ananya Saha is a prominent inventor based in Asansol, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid formulations for cancer treatment. With a total of three patents to her name, her work is paving the way for advancements in medical therapies.

Latest Patents

One of Ananya's latest patents focuses on stable liquid formulations of cyclophosphamide. This invention comprises cyclophosphamide and at least one pharmaceutically acceptable excipient, with a moisture content of less than about 2.0% by weight. The process involves reducing the moisture content from cyclophosphamide or its liquid compositions. Furthermore, the stable liquid formulations are designed for parenteral administration, either as ready-to-use or ready-to-dilute options for treating various cancer disorders.

Career Highlights

Ananya has worked with notable companies in the pharmaceutical industry, including Dr. Reddy's Laboratories and Avyxa Holdings. Her experience in these organizations has contributed to her expertise in developing innovative pharmaceutical solutions.

Collaborations

Ananya has collaborated with several professionals in her field, including Riyaz Ahmed Shaik and Svb Janardhan Garikipati. These collaborations have enhanced her research and development efforts, leading to impactful innovations.

Conclusion

Ananya Saha is a trailblazer in the pharmaceutical industry, with her inventions significantly improving cancer treatment options. Her dedication to innovation and collaboration continues to inspire advancements in medical formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…